Follow
Pat Price
Pat Price
Imperial College London
Verified email at patprice.co.uk
Title
Cited by
Cited by
Year
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
H Young, R Baum, U Cremerius, K Herholz, O Hoekstra, AA Lammertsma, ...
European journal of cancer 35 (13), 1773-1782, 1999
19721999
Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care
SR Cherry, T Jones, JS Karp, J Qi, WW Moses, RD Badawi
Journal of Nuclear Medicine 59 (1), 3-12, 2018
6532018
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
MO Leach, KM Brindle, JL Evelhoch, JR Griffiths, MR Horsman, A Jackson, ...
British journal of cancer 92 (9), 1599-1610, 2005
6142005
First human imaging studies with the EXPLORER total-body PET scanner
RD Badawi, H Shi, P Hu, S Chen, T Xu, PM Price, Y Ding, BA Spencer, ...
Journal of Nuclear Medicine 60 (3), 299-303, 2019
6102019
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases
P Price, PJ Hoskin, D Easton, D Austin, SG Palmer, JR Yarnold
Radiotherapy and Oncology 6 (4), 247-255, 1986
5721986
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
SC Winter, FM Buffa, P Silva, C Miller, HR Valentine, H Turley, KA Shah, ...
Cancer research 67 (7), 3441-3449, 2007
4132007
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results
GJS Rustin, SM Galbraith, H Anderson, M Stratford, LK Folkes, L Sena, ...
Journal of clinical oncology 21 (15), 2815-2822, 2003
3882003
3′-deoxy-3′-[18F] fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography
H Barthel, MC Cleij, DR Collingridge, OC Hutchinson, S Osman, Q He, ...
Cancer research 63 (13), 3791-3798, 2003
3722003
Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation
P Price, TJ McMillan
Cancer research 50 (5), 1392-1396, 1990
3621990
A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain
PJ Hoskin, P Price, D Easton, J Regan, D Austin, S Palmer, JR Yarnold
Radiotherapy and Oncology 23 (2), 74-78, 1992
3331992
Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate
HL Anderson, JT Yap, MP Miller, A Robbins, T Jones, PM Price
Journal of Clinical Oncology 21 (15), 2823-2830, 2003
2512003
X-ray volumetric imaging in image-guided radiotherapy: the new standard in on-treatment imaging
CA McBain, AM Henry, J Sykes, A Amer, T Marchant, CM Moore, J Davies, ...
International Journal of Radiation Oncology* Biology* Physics 64 (2), 625-634, 2006
2462006
Total-body imaging: transforming the role of positron emission tomography
SR Cherry, RD Badawi, JS Karp, WW Moses, P Price, T Jones
Science translational medicine 9 (381), eaaf6169, 2017
2362017
Tumour inoculation during laparoscopy
N O'Rourke, PM Price, S Kelly, K Sikora, L Fligelstone, M Rhodes, D Flook, ...
The Lancet 342 (8867), 368-369, 1993
2181993
Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies
P Workman, EO Aboagye, YL Chung, JR Griffiths, R Hart, MO Leach, ...
Journal of the National Cancer Institute 98 (9), 580-598, 2006
2162006
The development of [124I] iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography
DR Collingridge, VA Carroll, M Glaser, EO Aboagye, S Osman, ...
Cancer Research 62 (20), 5912-5919, 2002
1972002
A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients
L Rosso, CS Brock, JM Gallo, A Saleem, PM Price, FE Turkheimer, ...
Cancer research 69 (1), 120-127, 2009
1922009
Hypoxia-inducible factor 1α expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of …
GJ Hutchison, HR Valentine, JA Loncaster, SE Davidson, RD Hunter, ...
Clinical cancer research 10 (24), 8405-8412, 2004
1912004
The uptake of 3′-deoxy-3′-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels
H Barthel, M Perumal, J Latigo, Q He, F Brady, SK Luthra, PM Price, ...
European journal of nuclear medicine and molecular imaging 32, 257-263, 2005
1702005
Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancer
BA Gusterson, LG Machin, WJ Gullick, NM Gibbs, TJ Powles, P Price, ...
International journal of cancer 42 (6), 842-845, 1988
1641988
The system can't perform the operation now. Try again later.
Articles 1–20